[FDA CERSI] Synthetic Soup - What's Really in the US Drug Supply?

Nabarun Dasgupta

doi:10.17615/fcnr-hf03

May 8, 2026Open Access

[FDA CERSI] Synthetic Soup - What's Really in the US Drug Supply?

View Full Paper

Ask AI

Bookmark

Share

Key Points

This presentation aims to uncover the complexities within the US drug supply and its relation to overdose trends.
Presented at Triangle CERSI hosted by the FDA
Analyzed synthetic drug components within the supply chain
Explored regulatory science implications for drug safety
Identified key factors contributing to synthetic drug prevalence
Highlighted rising overdose rates linked to synthetic substances
Proposed regulatory approaches to enhance drug supply monitoring

Implication

Presentation explores the complexities of drug supply affecting overdose trends in the US, suggesting regulatory insights.

Abstract

Presentation for Triangle CERSI, hosted by the US Food and Drug Administration. https://www.fda.gov/science-research/advancing-regulatory-science/synthetic-soup-drug-supply-and-overdose-trends-05072026

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nabarun Dasgupta (2026) studied this question.

synapsesocial.com/papers/6a00217ac8f74e3340f9c6a9 https://doi.org/10.17615/fcnr-hf03

View Full Paper

Ask AI

Bookmark

Share

[FDA CERSI] Synthetic Soup - What's Really in the US Drug Supply?

Key Points

Implication

Abstract

Discussion

Cite This Study

[FDA CERSI] Synthetic Soup - What's Really in the US Drug Supply?

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading